Drawing for SUCAMPO

USPTO serial 77775918

SUCAMPO

Reviewed by CopyMark Law Group

Reg. 4324675Status 710
Filing date
Status date
Registration date
Apr 23, 2013
Examiner
YONTEF, DAVID ERIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SUCAMPO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sandra Edelman

Sandra Edelman Dorsey & Whitney LLP51 West 52nd StreetNew York, NY 10019-6119UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substance for the treatment of gastrointestinal diseases; pharmaceutical preparations for ophthalmic useSECTION 8 - CANCELLEDJun 30, 2006
016Printed matter, namely, books, pamphlets, leaflets, catalogs, brochures and reports in the field of medicine and pharmaceuticals; paper expanding files; paper file jacketsSECTION 8 - CANCELLEDJun 30, 2006
042Consultancy services in the area of science and technology, namely, medical research consultation and pharmaceutical research and development consultation; product research and development services, namely, research and development of pharmaceuticals; medical, pharmaceutical and scientific research for the healthcare field; pharmaceutical research services; medical researchSECTION 8 - CANCELLEDJun 30, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2019C8..CANCELLED SEC. 8 (6-YR)—
Apr 23, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 21, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 6, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 2, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 23, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2013SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 18, 2013REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Mar 12, 2013CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 19, 2013SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 14, 2013IUAFUSE AMENDMENT FILED—
Feb 14, 2013EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 14, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2012EX5GSOU EXTENSION 5 GRANTED—
Aug 7, 2012EXT5SOU EXTENSION 5 FILED—
Aug 7, 2012FAXXFAX RECEIVED—
Mar 28, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 27, 2012EX4GSOU EXTENSION 4 GRANTED—
Feb 1, 2012EXT4SOU EXTENSION 4 FILED—
Feb 1, 2012FAXXFAX RECEIVED—
Aug 11, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 10, 2011EX3GSOU EXTENSION 3 GRANTED—
Jul 27, 2011EXT3SOU EXTENSION 3 FILED—
Jul 27, 2011FAXXFAX RECEIVED—
Feb 24, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 23, 2011EX2GSOU EXTENSION 2 GRANTED—
Feb 16, 2011EXT2SOU EXTENSION 2 FILED—
Feb 16, 2011FAXXFAX RECEIVED—
Sep 9, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2010EX1GSOU EXTENSION 1 GRANTED—
Sep 7, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 26, 2010EXT1SOU EXTENSION 1 FILED—
Jul 26, 2010FAXXFAX RECEIVED—
Feb 23, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 1, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 1, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 27, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 27, 2009ALIEASSIGNED TO LIE—
Oct 8, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 8, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Oct 8, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 8, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 8, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 2, 2009DOCKASSIGNED TO EXAMINER—
Jul 10, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance